Skip to main navigation Skip to search Skip to main content

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

Christopher C. Parker, Nicholas D. James, Christopher D. Brawley, Noel W. Clarke, Alex P. Hoyle, Adnan Ali, Alastair W.S. Ritchie, Gerhardt Attard, Simon Chowdhury, William Cross, David P. Dearnaley, Silke Gillessen, Clare Gilson, Robert J. Jones, Ruth E. Langley, Zafar I. Malik, Malcolm D. Mason, David Matheson, Robin Millman, J. Martin RussellGeorge N. Thalmann, Claire L. Amos, Roberto Alonzi, Amit Bahl, Alison Birtle, Omar Din, Hassan Douis, Chinnamani Eswar, Joanna Gale, Melissa R. Gannon, Sai Jonnada, Sara Khaksar, Jason F. Lester, Joe M. O'Sullivan, Omi A. Parikh, Ian D. Pedley, Delia M. Pudney, Denise J. Sheehan, Narayanan Nair Srihari, Anna T.H. Tran, Mahesh K.B. Parmar, Matthew R. Sydes*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1069 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry